Symptomatic infection withBlastocystissp. subtype 8 successfully treated with trimethoprim–sulfamethoxazole
about
Update on the pathogenic potential and treatment options for Blastocystis spBlastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasiteIn Vitro Antimicrobial Susceptibility Patterns of BlastocystisIntra-subtype variation in enteroadhesion accounts for differences in epithelial barrier disruption and is associated with metronidazole resistance in Blastocystis subtype-7Intestinal parasitic infections in HIV/AIDS patients presenting with diarrhoea in Jakarta, Indonesia.Changing trends in intestinal parasitic infections among long-term-residents and settled immigrants in Qatar.Blastocystis, an unrecognized parasite: an overview of pathogenesis and diagnosisA rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities.Blastocystis sp. subtype 4 is common in Danish Blastocystis-positive patients presenting with acute diarrheaPrevalence of blastocystis in shelter-resident and client-owned companion animals in the US Pacific NorthwestNew insights on classification, identification, and clinical relevance of Blastocystis spp.Blastocystis: Genetic diversity and molecular methods for diagnosis and epidemiology.Diversity and distribution of Blastocystis sp. subtypes in non-human primates.Molecular epidemiology of blastocystosis in Malaysia: does seasonal variation play an important role in determining the distribution and risk factors of Blastocystis subtype infections in the Aboriginal community?Increase number of mitochondrion-like organelle in symptomatic Blastocystis subtype 3 due to metronidazole treatment.Subtype distribution of Blastocystis isolates identified in a Sydney population and pathogenic potential of Blastocystis.Comparative Study of Wheatley’s Trichrome Stain and In-vitro Culture against PCR Assay for the Diagnosis of Blastocystis sp. in Stool Samples.
P2860
Q27022138-F5C069F7-8310-4FA3-BAAF-A90B6B2365FAQ28242611-899DB4A8-2994-4E3D-84A1-F4A69ABC1F66Q28262140-FFF518DB-A63C-46DE-9574-04B2DD7614D6Q28539056-D98197E5-459B-4F34-824E-03C7ECAAB335Q33423370-D886B9E1-5DC9-4EC2-B9B9-CB8097097250Q34273652-6C89C742-24AC-4248-870D-857D6D354270Q34435613-001E1E1E-9064-4A2F-BD56-18D5EB2122EEQ34528996-AB477EC0-1068-4E59-9B0C-6DBB65290540Q35031875-703D4337-3A79-4B15-96E9-E161B825F24EQ35255693-737829BB-BE17-4CAB-94A1-F5027583F350Q36943143-2ABCF6D0-674E-4AF0-99E5-59E35CDB7943Q38130267-B576A78B-7527-4CF2-942E-76E42CFAB3CAQ38868340-F73B3D11-80D2-4847-92B6-ED7A41425D11Q39308826-D7B467D9-4131-4071-985E-D7544B41466BQ40945949-97E3D1A3-4FBE-44DB-A70B-30F4BF08F907Q54291234-6A283D3F-FC9E-49C8-BD5A-DAB04774EDF3Q55364028-2DF32E03-387D-4A11-A1BF-F7351839E50E
P2860
Symptomatic infection withBlastocystissp. subtype 8 successfully treated with trimethoprim–sulfamethoxazole
description
im April 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 April 2008
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2008
@uk
name
Symptomatic infection withBlas ...... trimethoprim–sulfamethoxazole
@en
Symptomatic infection withBlas ...... trimethoprim–sulfamethoxazole
@nl
type
label
Symptomatic infection withBlas ...... trimethoprim–sulfamethoxazole
@en
Symptomatic infection withBlas ...... trimethoprim–sulfamethoxazole
@nl
prefLabel
Symptomatic infection withBlas ...... trimethoprim–sulfamethoxazole
@en
Symptomatic infection withBlas ...... trimethoprim–sulfamethoxazole
@nl
P2860
P50
P356
P1476
Symptomatic infection with Bla ...... trimethoprim-sulfamethoxazole
@en
P2093
P2860
P304
P356
10.1179/136485908X278847
P577
2008-04-01T00:00:00Z